| Financial Year |
March 31 2023 |
| Monetary Funds |
22,515,664,743.86 |
| Held-for-trading Financial Assets |
1,457,875,145.59 |
| Notes Receivable |
4,426,864,032.22 |
| Accounts Receivable |
12,946,297,465.81 |
| Advances to Suppliers |
4,372,904,545.56 |
| Other Receivables |
644,028,576.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
4,581,501.70 |
| Inventories |
16,641,680,871.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
783,033.63 |
| Other Current Assets |
267,058,871.29 |
| Total Current Assets |
64,539,884,344.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,579,416.25 |
| Long-term Equity Investment |
1,044,893,232.54 |
| Investment Properties |
538,526,379.78 |
| Fixed Assetes |
12,744,910,204.06 |
| Under-construction Projects |
4,249,003,836.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,879,512,422.73 |
| R&D expenses |
18,846,849.23 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
202,007,346.19 |
| Deferred Income Tax Assets |
658,524,482.26 |
| Other Non-Current Assets |
512,732,848.13 |
| Sub-Total of Non-Current Assets |
24,713,518,684.91 |
| Total Assets |
89,253,403,029.09 |
| Short-Term Loans |
2,390,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,599,699,167.69 |
| Accounts Payable |
10,871,016,558.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
167,832,171.22 |
| Taxes Payable |
250,585,736.12 |
| Interest Payable |
-- |
| Dividend Payable |
20,513,316.01 |
| Other payables |
1,042,580,177.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,265,890,251.10 |
| Other Current Liabilities |
1,346,089,879.31 |
| Sub-Total of Current Liabilities |
32,361,537,688.12 |
| Long-term Loans |
4,842,592,000.00 |
| Bonds Payable |
2,194,607,370.15 |
| Long-Term Accounts Payable |
1,292,860,705.47 |
| Special Payable |
-- |
| Estimatied Liabilities |
490,894,845.57 |
| Deferred Income Tax Liabilities |
62,265,073.48 |
| Other Non-Current Liabilities |
1,102,275,953.40 |
| Sub-Total of Non-Current Liabilities |
11,180,539,088.92 |
| Total Liabilities |
43,542,076,777.04 |
| Paid-In Capital(Or Share Stock) |
2,160,682,115.00 |
| Capital Surplus |
25,588,075,991.61 |
| Surplus Reserve |
656,868,966.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,725,743,888.90 |
| Minority Stockholder's Interest |
10,120,435,265.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
35,590,890,986.55 |
| Owner's Equity（Stockholder's Equity） |
45,711,326,252.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
89,253,403,029.09 |
